MA58991B1 - Nucléosides et nucléotides avec groupe de blocage acétal 3' - Google Patents

Nucléosides et nucléotides avec groupe de blocage acétal 3'

Info

Publication number
MA58991B1
MA58991B1 MA58991A MA58991A MA58991B1 MA 58991 B1 MA58991 B1 MA 58991B1 MA 58991 A MA58991 A MA 58991A MA 58991 A MA58991 A MA 58991A MA 58991 B1 MA58991 B1 MA 58991B1
Authority
MA
Morocco
Prior art keywords
blocking group
nucleotide
nucleoside
nucleosides
nucleotides
Prior art date
Application number
MA58991A
Other languages
English (en)
Other versions
MA58991A1 (fr
Inventor
Francais Antoine
Elena CRESSINA
Angelica MARIANI
Adam Culley
Anno Koetje
Xiaohai Liu
Original Assignee
Illumina Cambridge Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Illumina Cambridge Limited filed Critical Illumina Cambridge Limited
Publication of MA58991A1 publication Critical patent/MA58991A1/fr
Publication of MA58991B1 publication Critical patent/MA58991B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/02—Phosphorylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/117—Modifications characterised by incorporating modified base
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/101—Sanger sequencing method, i.e. oligonucleotide sequencing using primer elongation and dideoxynucleotides as chain terminators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention concerne un nucléoside ou un nucléotide comprenant une nucléobase attachée à une étiquette détectable par l'intermédiaire d'un lieur clivable, le nucléoside ou le nucléotide comprenant une fraction ribose ou 2' désoxyribose et un groupe de blocage 3'-OH, et le lieur clivable comprenant une fraction de la structure (I), chacun de X et Y étant indépendamment O ou S ; et chacun de R<sup>1a</sup> <sup>,</sup> R<sup>2b,</sup> R<sup>2,</sup> R<sup>3a</sup> et R<sup>3b</sup> représentant indépendamment H, l'halogène, l'alkyle en C<sub>1</sub>-C<sub>6</sub> substitué ou non substitué ou l'haloalkyle en C<sub>1</sub>-C<sub>6</sub>. La présente invention concerne également des procédés de préparation de ces molécules de nucléotides et de nucléosides, et les utilisations de nucléotides entièrement fonctionnalisés contenant le groupe de blocage acétal 3' pour des applications de séquençage.
MA58991A 2020-06-22 2021-06-21 Nucléosides et nucléotides avec groupe de blocage acétal 3' MA58991B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063042240P 2020-06-22 2020-06-22
PCT/EP2021/066886 WO2021259881A1 (fr) 2020-06-22 2021-06-21 Nucléosides et nucléotides avec groupe de blocage acétal 3'

Publications (2)

Publication Number Publication Date
MA58991A1 MA58991A1 (fr) 2023-03-31
MA58991B1 true MA58991B1 (fr) 2024-09-30

Family

ID=76765108

Family Applications (1)

Application Number Title Priority Date Filing Date
MA58991A MA58991B1 (fr) 2020-06-22 2021-06-21 Nucléosides et nucléotides avec groupe de blocage acétal 3'

Country Status (16)

Country Link
US (3) US11787831B2 (fr)
EP (1) EP4168421A1 (fr)
JP (1) JP7797426B2 (fr)
KR (1) KR20230031837A (fr)
CN (2) CN115867560B (fr)
AU (1) AU2021295081A1 (fr)
BR (1) BR112022026056A2 (fr)
CA (1) CA3177293A1 (fr)
CL (1) CL2022003661A1 (fr)
CO (1) CO2022018487A2 (fr)
IL (2) IL316161A (fr)
MA (1) MA58991B1 (fr)
MX (1) MX2022016492A (fr)
PE (1) PE20230492A1 (fr)
WO (1) WO2021259881A1 (fr)
ZA (1) ZA202211847B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11293061B2 (en) 2018-12-26 2022-04-05 Illumina Cambridge Limited Sequencing methods using nucleotides with 3′ AOM blocking group
WO2021259881A1 (fr) 2020-06-22 2021-12-30 Illumina Cambridge Limited Nucléosides et nucléotides avec groupe de blocage acétal 3'
CN117916390A (zh) * 2021-05-20 2024-04-19 伊鲁米纳公司 用于边合成边测序的组合物和方法
US20230212667A1 (en) 2021-12-29 2023-07-06 Illumina Cambridge Limited Methods of nucleic acid sequencing using surface-bound primers
EP4511512A2 (fr) 2022-05-27 2025-02-26 Illumina, Inc. Nucléotides bloqués en 3', leurs procédés de déblocage et procédés de synthèse de polynucléotides y faisant appel
US20240141427A1 (en) 2022-09-30 2024-05-02 Illumina, Inc. Polymerases, compositions, and methods of use
US20260035744A1 (en) * 2022-10-09 2026-02-05 Genemind Biosciences Co., Ltd. Method for reducing azidomethoxy group, sequencing method, and kit
CA3246536A1 (fr) 2022-12-22 2024-06-27 Illumina, Inc. Compositions de catalyseur de métal de transition et procédés de séquençage par synthèse
AU2023409219A1 (en) 2022-12-22 2024-10-03 Illumina, Inc. Palladium catalyst compositions and methods for sequencing by synthesis
CN119095984A (zh) 2022-12-27 2024-12-06 伊路米纳有限公司 使用3'烯丙基封端的核苷酸的测序方法
EP4689181A1 (fr) 2023-03-30 2026-02-11 Illumina, Inc. Compositions et procédés de séquençage d'acides nucléiques
EP4720339A1 (fr) 2023-05-31 2026-04-08 Illumina, Inc. Procédés de séquençage double brin par synthèse
WO2025003459A1 (fr) 2023-06-30 2025-01-02 Illumina, Inc. Protection de nucléotides entièrement fonctionnels contre la dégradation
WO2025062002A1 (fr) 2023-09-20 2025-03-27 Illumina, Inc. Séquençage simultané à l'aide d'une traduction de coupure simple brin
CN117510493A (zh) * 2023-11-06 2024-02-06 重庆华邦胜凯制药有限公司 用于去除磷酸芦可替尼及其中间体中重金属钯的方法
WO2025184226A1 (fr) 2024-02-28 2025-09-04 Illumina, Inc. Nucléotides à coiffage terminal de phosphate
WO2025230914A1 (fr) * 2024-04-29 2025-11-06 Illumina, Inc. Nucléotides avec lieurs auto-immolables déclenchés par des enzymes pour le séquençage par synthèse
WO2025230760A1 (fr) * 2024-04-30 2025-11-06 Illumina, Inc. Nucléotides à terminaison réversible avec chaînes de phosphate modifiées, et leurs procédés de fabrication et d'utilisation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002029003A2 (fr) * 2000-10-06 2002-04-11 The Trustees Of Columbia University In The City Of New York Methode d'analyse massivement parallele destinee a decoder l'adn et l'arn
WO2004018497A2 (fr) * 2002-08-23 2004-03-04 Solexa Limited Nucleotides modifies
WO2004018493A1 (fr) * 2002-08-23 2004-03-04 Solexa Limited Nucleotides marques
US20130079232A1 (en) * 2011-09-23 2013-03-28 Illumina, Inc. Methods and compositions for nucleic acid sequencing

Family Cites Families (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936696A (ja) 1982-08-20 1984-02-28 Taiho Yakuhin Kogyo Kk ２′―デオキシ―５―置換ウリジン誘導体及びそれを含有する抗腫瘍剤
EP0104857A1 (fr) 1982-09-28 1984-04-04 Beecham Group Plc Dérivés de la déoxyuridine, leurs méthodes de préparation et leur emploi en médecine
US4772691A (en) 1985-06-05 1988-09-20 The Medical College Of Wisconsin, Inc. Chemically cleavable nucleotides
DE3529478A1 (de) 1985-08-16 1987-02-19 Boehringer Mannheim Gmbh 7-desaza-2'desoxyguanosin-nukleotide, verfahren zu deren herstellung und deren verwendung zur nukleinsaeure-sequenzierung
US5242796A (en) 1986-07-02 1993-09-07 E. I. Du Pont De Nemours And Company Method, system and reagents for DNA sequencing
GB8822228D0 (en) 1988-09-21 1988-10-26 Southern E M Support-bound oligonucleotides
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US6346413B1 (en) 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
DE3924454A1 (de) 1989-07-24 1991-02-07 Cornelis P Prof Dr Hollenberg Die anwendung von dna und dna-technologie fuer die konstruktion von netzwerken zur verwendung in der chip-konstruktion und chip-produktion (dna chips)
US5302509A (en) 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
EP0450060A1 (fr) 1989-10-26 1991-10-09 Sri International Sequen age d'adn
DK0604552T3 (da) 1991-09-18 1997-08-04 Affymax Tech Nv Fremgangsmåde til syntese af forskellige samlinger af oligomerer
US5677195A (en) 1991-11-22 1997-10-14 Affymax Technologies N.V. Combinatorial strategies for polymer synthesis
AU3728093A (en) 1992-02-19 1993-09-13 Public Health Research Institute Of The City Of New York, Inc., The Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids
US5583211A (en) 1992-10-29 1996-12-10 Beckman Instruments, Inc. Surface activated organic polymers useful for location - specific attachment of nucleic acids, peptides, proteins and oligosaccharides
US5472672A (en) 1993-10-22 1995-12-05 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and method for polymer synthesis using arrays
US6156501A (en) 1993-10-26 2000-12-05 Affymetrix, Inc. Arrays of modified nucleic acid probes and methods of use
DE69433180T2 (de) 1993-10-26 2004-06-24 Affymetrix, Inc., Santa Clara Felder von nukleinsaeuresonden auf biologischen chips
US5429807A (en) 1993-10-28 1995-07-04 Beckman Instruments, Inc. Method and apparatus for creating biopolymer arrays on a solid support surface
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US6232465B1 (en) 1994-09-02 2001-05-15 Andrew C. Hiatt Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides
US5846719A (en) 1994-10-13 1998-12-08 Lynx Therapeutics, Inc. Oligonucleotide tags for sorting and identification
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
AU5171696A (en) 1995-02-27 1996-09-18 Ely Michael Rabani Device, compounds, algorithms, and methods of molecular characterization and manipulation with molecular parallelism
US5750341A (en) 1995-04-17 1998-05-12 Lynx Therapeutics, Inc. DNA sequencing by parallel oligonucleotide extensions
US5624711A (en) 1995-04-27 1997-04-29 Affymax Technologies, N.V. Derivatization of solid supports and methods for oligomer synthesis
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
WO1997014028A2 (fr) 1995-10-11 1997-04-17 Luminex Corporation Procedes et appareil d'analyse multiplexee de specimens cliniques
US5658734A (en) 1995-10-17 1997-08-19 International Business Machines Corporation Process for synthesizing chemical compounds
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
GB9620209D0 (en) 1996-09-27 1996-11-13 Cemu Bioteknik Ab Method of sequencing DNA
GB9626815D0 (en) 1996-12-23 1997-02-12 Cemu Bioteknik Ab Method of sequencing DNA
US6297006B1 (en) 1997-01-16 2001-10-02 Hyseq, Inc. Methods for sequencing repetitive sequences and for determining the order of sequence subfragments
US6136543A (en) 1997-01-31 2000-10-24 Hitachi, Ltd. Method for determining nucleic acids base sequence and apparatus therefor
EP1591541B1 (fr) 1997-04-01 2012-02-15 Illumina Cambridge Limited Methode de séquençage d'acide nucléique
EP1498494A3 (fr) 1997-04-01 2007-06-20 Solexa Ltd. Procédé de séquencage d'acides nucléiques
US6969488B2 (en) 1998-05-22 2005-11-29 Solexa, Inc. System and apparatus for sequential processing of analytes
EP0985142A4 (fr) 1997-05-23 2006-09-13 Lynx Therapeutics Inc Systeme et appareil destines au traitement sequentiel des analytes
US6465178B2 (en) 1997-09-30 2002-10-15 Surmodics, Inc. Target molecule attachment to surfaces
US6485944B1 (en) 1997-10-10 2002-11-26 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
CA2305449A1 (fr) 1997-10-10 1999-04-22 President & Fellows Of Harvard College Amplification par replique de reseaux d'acides nucleiques
US6087102A (en) 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US6287776B1 (en) 1998-02-02 2001-09-11 Signature Bioscience, Inc. Method for detecting and classifying nucleic acid hybridization
JP3944996B2 (ja) 1998-03-05 2007-07-18 株式会社日立製作所 Ｄｎａプローブアレー
US6031078A (en) 1998-06-16 2000-02-29 Millennium Pharmaceuticals, Inc. MTbx protein and nucleic acid molecules and uses therefor
US6335155B1 (en) 1998-06-26 2002-01-01 Sunesis Pharmaceuticals, Inc. Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
GB0002310D0 (en) 2000-02-01 2000-03-22 Solexa Ltd Polynucleotide sequencing
WO2000006770A1 (fr) 1998-07-30 2000-02-10 Solexa Ltd. Biomolecules en rangees et leur utilisation dans une procedure de sequençage
AR021833A1 (es) 1998-09-30 2002-08-07 Applied Research Systems Metodos de amplificacion y secuenciacion de acido nucleico
US6277628B1 (en) 1998-10-02 2001-08-21 Incyte Genomics, Inc. Linear microarrays
US6391937B1 (en) 1998-11-25 2002-05-21 Motorola, Inc. Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers
US6255476B1 (en) * 1999-02-22 2001-07-03 Pe Corporation (Ny) Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
EP1159453B1 (fr) 1999-03-10 2008-05-28 ASM Scientific, Inc. Procede de sequencage direct d'acides nucleiques
CA2370976C (fr) 1999-04-20 2009-10-20 Illumina, Inc. Detection de reactions d'acide nucleique sur microsupports de billes en reseau
US6355431B1 (en) 1999-04-20 2002-03-12 Illumina, Inc. Detection of nucleic acid amplification reactions using bead arrays
US6664061B2 (en) 1999-06-25 2003-12-16 Amersham Biosciences Ab Use and evaluation of a [2+2] photoaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix
US6372813B1 (en) 1999-06-25 2002-04-16 Motorola Methods and compositions for attachment of biomolecules to solid supports, hydrogels, and hydrogel arrays
US6274320B1 (en) 1999-09-16 2001-08-14 Curagen Corporation Method of sequencing a nucleic acid
US6770441B2 (en) 2000-02-10 2004-08-03 Illumina, Inc. Array compositions and methods of making same
US7001792B2 (en) 2000-04-24 2006-02-21 Eagle Research & Development, Llc Ultra-fast nucleic acid sequencing device and a method for making and using the same
GB0013276D0 (en) 2000-06-01 2000-07-26 Amersham Pharm Biotech Uk Ltd Nucleotide analogues
ATE377093T1 (de) 2000-07-07 2007-11-15 Visigen Biotechnologies Inc Sequenzbestimmung in echtzeit
AU2001279244A1 (en) 2000-08-09 2002-02-18 Motorola, Inc. The use and evaluation of a (2+2) photocycloaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix
US7211414B2 (en) 2000-12-01 2007-05-01 Visigen Biotechnologies, Inc. Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
US7057026B2 (en) 2001-12-04 2006-06-06 Solexa Limited Labelled nucleotides
GB0321306D0 (en) 2003-09-11 2003-10-15 Solexa Ltd Modified polymerases for improved incorporation of nucleotide analogues
GB0326073D0 (en) 2003-11-07 2003-12-10 Solexa Ltd Improvements in or relating to polynucleotide arrays
US20110059865A1 (en) 2004-01-07 2011-03-10 Mark Edward Brennan Smith Modified Molecular Arrays
US20060062531A1 (en) 2004-09-17 2006-03-23 Stephen Turner Fabrication of optical confinements
US8623628B2 (en) 2005-05-10 2014-01-07 Illumina, Inc. Polymerases
GB0514936D0 (en) 2005-07-20 2005-08-24 Solexa Ltd Preparation of templates for nucleic acid sequencing
GB0517097D0 (en) 2005-08-19 2005-09-28 Solexa Ltd Modified nucleosides and nucleotides and uses thereof
US7405281B2 (en) 2005-09-29 2008-07-29 Pacific Biosciences Of California, Inc. Fluorescent nucleotide analogs and uses therefor
WO2007123744A2 (fr) 2006-03-31 2007-11-01 Solexa, Inc. Systèmes et procédés pour analyse de séquençage par synthèse
US7754429B2 (en) 2006-10-06 2010-07-13 Illumina Cambridge Limited Method for pair-wise sequencing a plurity of target polynucleotides
US8343746B2 (en) 2006-10-23 2013-01-01 Pacific Biosciences Of California, Inc. Polymerase enzymes and reagents for enhanced nucleic acid sequencing
DE112007002932B4 (de) 2006-12-01 2015-08-06 The Trustees Of Columbia University In The City Of New York Vierfarben DNA-Sequenzierung mittels Synthese unter Verwendung von abspaltbaren, reversiblen, fluoreszierenden Nucleotidterminatoren
US8349167B2 (en) 2006-12-14 2013-01-08 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
EP2639578B1 (fr) 2006-12-14 2016-09-14 Life Technologies Corporation Appareil de mesure d'analytes à l'aide de matrices de FET à grande échelle
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
US9115163B2 (en) 2007-10-19 2015-08-25 The Trustees Of Columbia University In The City Of New York DNA sequence with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators
US8617811B2 (en) 2008-01-28 2013-12-31 Complete Genomics, Inc. Methods and compositions for efficient base calling in sequencing reactions
US20100137143A1 (en) 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US8951781B2 (en) 2011-01-10 2015-02-10 Illumina, Inc. Systems, methods, and apparatuses to image a sample for biological or chemical analysis
US9624539B2 (en) 2011-05-23 2017-04-18 The Trustees Of Columbia University In The City Of New York DNA sequencing by synthesis using Raman and infrared spectroscopy detection
WO2013041117A1 (fr) 2011-09-23 2013-03-28 Illumina Cambrigde Ltd. Colorants pour le marquage de ligands moléculaires
US9012022B2 (en) 2012-06-08 2015-04-21 Illumina, Inc. Polymer coatings
US9150896B2 (en) 2012-09-06 2015-10-06 Illumina, Inc. Nucleotides and primers with removable blocking groups
EP2964612B1 (fr) 2013-03-08 2017-02-01 Illumina Cambridge Limited Composés de polyméthine et leur utilisation comme marqueurs fluorescents
US8754244B1 (en) 2013-03-08 2014-06-17 Illumina Cambridge Limited Rhodamine compounds and their use as fluorescent labels
KR102230831B1 (ko) 2013-03-15 2021-03-22 일루미나 케임브리지 리미티드 변형된 뉴클레오사이드 또는 뉴클레오타이드
GB201414098D0 (en) 2014-08-08 2014-09-24 Illumina Cambridge Ltd Modified nucleotide linkers
GB201508858D0 (en) 2015-05-22 2015-07-01 Illumina Cambridge Ltd Polymethine compounds with long stokes shifts and their use as fluorescent labels
GB201516987D0 (en) 2015-09-25 2015-11-11 Illumina Cambridge Ltd Polymethine compounds and their use as fluorescent labels
WO2017079498A2 (fr) * 2015-11-06 2017-05-11 Intelligent Biosystems, Inc. Analogues nucléotidiques
CN105315318B (zh) 2015-11-06 2019-04-19 山东大学 一种α‐L‐鼠李糖苷酶在制备5-氟-2’-脱氧脲苷衍生物中的应用
CN109641931B (zh) * 2016-06-21 2022-10-18 基因设计有限公司 核糖核酸h-磷酸酯单体的合成方法和使用了该单体的寡核苷酸合成
JP2018008186A (ja) 2016-07-11 2018-01-18 三菱ケミカル株式会社 水不溶性金属捕集剤、貴金属の回収方法および貴金属回収設備
EP3491001A1 (fr) * 2016-07-27 2019-06-05 Roche Innovation Center Copenhagen A/S Nucléotides et oligonucléotides de 5's-lna
US10385214B2 (en) 2016-09-30 2019-08-20 Illumina Cambridge Limited Fluorescent dyes and their uses as biomarkers
CN109476674B (zh) 2016-12-22 2021-12-10 伊鲁米纳剑桥有限公司 香豆素化合物及其作为荧光标记物的用途
CA3048486A1 (fr) 2017-01-04 2018-07-12 Complete Genomics, Inc. Sequencage par etapes par des terminateurs reversibles non marques ou des nucleotides naturels
US11492367B2 (en) 2017-01-27 2022-11-08 Janssen Biotech, Inc. Cyclic dinucleotides as sting agonists
GB201716931D0 (en) 2017-10-16 2017-11-29 Illumina Cambridge Ltd New fluorescent compounds and their use as biomarkers
WO2019183272A1 (fr) 2018-03-21 2019-09-26 Centrillion Technologies, Inc. Procédé et système de fabrication de réseaux de séquençage d'adn
US12084474B2 (en) 2018-05-15 2024-09-10 Illumina, Inc. Compositions and methods for chemical cleavage and deprotection of surface-bound oligonucleotides
CA3103719A1 (fr) 2018-10-31 2020-05-07 Illumina, Inc. Polymerases, compositions et procedes d'utilisation
CN120082639A (zh) 2018-11-09 2025-06-03 深圳华大智造科技股份有限公司 使用未标记的核苷酸进行大规模平行测序
CA3103739A1 (fr) 2018-12-05 2020-06-11 Illumina, Inc. Polymerases, compositions et procedes d'utilisation
WO2020126593A1 (fr) 2018-12-17 2020-06-25 Illumina Cambridge Limited Compositions destinées à être utilisées dans le séquençage de polynucléotides
US20240182963A1 (en) 2018-12-26 2024-06-06 Illumina, Inc. Methods of sequencing using 3' blocked nucleotides
US11293061B2 (en) 2018-12-26 2022-04-05 Illumina Cambridge Limited Sequencing methods using nucleotides with 3′ AOM blocking group
MY209343A (en) 2019-03-01 2025-07-03 Illumina Cambridge Ltd Exocyclic amine substituted coumarin compounds and uses as fluorescent labels
KR102865446B1 (ko) 2019-03-01 2025-09-29 일루미나 케임브리지 리미티드 삼차 아민 치환된 쿠마린 화합물 및 형광 표지로서의 이의 용도
CA3144528A1 (fr) 2019-12-23 2021-07-01 Illumina, Inc. Nanoparticule a site unique pour la fixation de polynucleotide de matrice
WO2021259881A1 (fr) 2020-06-22 2021-12-30 Illumina Cambridge Limited Nucléosides et nucléotides avec groupe de blocage acétal 3'
US20240209015A1 (en) 2020-06-22 2024-06-27 Illumina, Inc. Methods of sequencing using 3' blocked nucleotides
US11981964B2 (en) 2020-07-28 2024-05-14 Illumina Cambridge Limited Substituted coumarin dyes and uses as fluorescent labels
US20220195517A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Long stokes shift chromenoquinoline dyes and uses in sequencing applications
JP2024516191A (ja) 2021-05-05 2024-04-12 イルミナ ケンブリッジ リミテッド ビス－ホウ素縮合複素環を含有する蛍光色素及び配列決定における使用
CN117916390A (zh) 2021-05-20 2024-04-19 伊鲁米纳公司 用于边合成边测序的组合物和方法
US20240218443A1 (en) 2021-05-20 2024-07-04 Illumina, Inc. Methods of sequencing using 3' blocked nucleotides
AU2023246772A1 (en) 2022-03-29 2024-01-18 Illumina Inc. Chromenoquinoline dyes and uses in sequencing
AU2023281871A1 (en) 2022-05-31 2024-11-14 Illumina, Inc Compositions and methods for nucleic acid sequencing
CA3259955A1 (fr) 2022-06-28 2024-01-04 Illumina, Inc. Colorants fluorescents contenant un hétérocycle de bore bis tétracyclique fusionné et leurs utilisations dans le séquençage
CN119095984A (zh) 2022-12-27 2024-12-06 伊路米纳有限公司 使用3'烯丙基封端的核苷酸的测序方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002029003A2 (fr) * 2000-10-06 2002-04-11 The Trustees Of Columbia University In The City Of New York Methode d'analyse massivement parallele destinee a decoder l'adn et l'arn
WO2004018497A2 (fr) * 2002-08-23 2004-03-04 Solexa Limited Nucleotides modifies
WO2004018493A1 (fr) * 2002-08-23 2004-03-04 Solexa Limited Nucleotides marques
US20130079232A1 (en) * 2011-09-23 2013-03-28 Illumina, Inc. Methods and compositions for nucleic acid sequencing

Also Published As

Publication number Publication date
CA3177293A1 (fr) 2021-12-30
US20240132532A1 (en) 2024-04-25
MA58991A1 (fr) 2023-03-31
CN115867560A (zh) 2023-03-28
US11787831B2 (en) 2023-10-17
US12286453B2 (en) 2025-04-29
AU2021295081A1 (en) 2022-12-08
BR112022026056A2 (pt) 2023-03-07
IL297992B1 (en) 2024-11-01
IL297992B2 (en) 2025-03-01
IL316161A (en) 2024-12-01
MX2022016492A (es) 2023-03-06
CL2022003661A1 (es) 2023-06-09
JP7797426B2 (ja) 2026-01-13
PE20230492A1 (es) 2023-03-23
KR20230031837A (ko) 2023-03-07
JP2023531009A (ja) 2023-07-20
US20210403500A1 (en) 2021-12-30
CN115867560B (zh) 2025-03-28
ZA202211847B (en) 2024-02-28
IL297992A (en) 2023-01-01
CO2022018487A2 (es) 2023-03-07
WO2021259881A1 (fr) 2021-12-30
US20250236635A1 (en) 2025-07-24
EP4168421A1 (fr) 2023-04-26
CN120174072A (zh) 2025-06-20

Similar Documents

Publication Publication Date Title
ZA202211847B (en) Nucleosides and nucleotides with 3&#39; acetal blocking group
US6043060A (en) Nucleotide analogues
AU720472B2 (en) Novel bicyclonucleoside and oligonucleotide analogue
EP1284741B1 (fr) Derives de nucleoside substitues par 3&#39;- ou 2&#39;-hydroxymethyle utilises dans le traitement des infections imputables au virus
Xu et al. Synthesis by post-synthetic substitution of oligomers containing guanine modified at the 6-position with S-, N-, O-derivatives
WO2004018497A3 (fr) Nucleotides modifies
WO2008016909A3 (fr) Analogues de nucléotides
DE60029314D1 (de) VERBESSERTE SYNTHESE FÜR i2.2.1.öBICYCLO-NUKLEOSIDE
KR101279393B1 (ko) 보호된 3&#39;-아미노 뉴클레오시드 단량체의 합성
Lin et al. Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents
Eisenhuth et al. Convenient syntheses of 3′-amino-2′, 3′-dideoxynucleosides, their 5′-monophosphates, and 3′-aminoterminal oligodeoxynucleotide primers
EP1753774B1 (fr) Ribonucleotides modifies par 2&#39;-nitrobenzyle
US5817799A (en) 2&#39;-Fluorofuranosyl derivatives and methods for preparing 2&#39;-fluoropyrimidine and 2&#39;-fluoropurine nucleosides
Abou-Elkhair et al. Synthesis and biological evaluation of 2-oxonicotinonitriles and 2-oxonicotinonitrile based nucleoside analogues
Kitade et al. Facile synthesis of 9-[(1′ R, 2′ S)-2′-hydroxy-3′-oxocyclopentan-1′-yl]-9-H-adenine possessing inhibitory activity against human recombinant S-adenosyl-l-homocysteine hydrolase
WO2001012644A1 (fr) Dinucleoside 5&#39;,5&#39;-tetraphosphates comme inhibiteurs de transcriptase inverse virale et de virus
Gupta et al. Facile, chemoenzymatic synthesis of the potent antiviral compound, 2-acetonylinosine
Gadthula et al. Synthesis and anti-HIV activity of β-D-3′-azido-2′, 3′-unsaturated nucleosides and β-D-3′-azido-3′-deoxyribofuranosylnucleosides
Kumar et al. Synthesis of a phosphoramidate pro-drug of 6-thio-7-deaza-2′-deoxyguanosine (TDG): a regioselective phosphorylation
Yamada et al. Synthesis of RNA Crosslinking Oligonucleotides Modified with 2‐Amino‐7‐Deaza‐7‐Propynyl‐6‐Vinylpurine
Van Ostrand et al. Synthesis and antibacterial activity of 5′-tetrachlorophthalimido and 5′-azido 5′-deoxyribonucleosides
WO2002074910A2 (fr) Terminateurs de chaine de nucleosides antiviraux selectifs
Kvasyuk et al. Synthesis and biological activity of 2′, 5′-oligoadenylate trimers containing 5′-terminal 5′-amino-5′-deoxy-and 5′-amino-3′, 5′-dideoxyadenosine derivatives
Ozaki et al. Effect of the terminal amino group of a linker arm and its length at the C5 position of a pyrimidine nucleoside on the thermal stability of DNA duplexes
Milisavljević Modified ribonucleotides as building blocks for enzymatic construction of functionalized RNA or as antiviral compounds